Shardstar18 Mar 2021 19:01
Paraytec will now progress to a prospective clinical validation with a larger number of patient samples and seek to obtain a CE mark for the test. Depending on location, the prospective clinical trial (where individual patient outcomes are monitored over time) is expected to take two months to complete and a further update is expected to be made by the end of April 2021. As previously stated, Paraytec are seeking manufacturers and licensees to take the product to the global market, with first product manufacture expected in six months, subject to regulatory approval.